DJ Moderna Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. $(MRNA)$ tumbled 16.80% to $35.15 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.86% to 42,297.12 and the NASDAQ Composite Index falling 0.38% to 19,088.10.
This was the stock's third consecutive day of losses.
Moderna Inc. closed $135.32 below its 52-week high ($170.47), which the company achieved on May 24th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.70% to $144.47 and Pfizer Inc. $(PFE)$ rose 0.30% to $26.80.
Trading volume (33.4 M) eclipsed its 50-day average volume of 9.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 13, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 13, 2025 17:17 ET (22:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.